WS
CALA

Wedbush Securities’s Calithera Biosciences, Inc CALA Stock Holding History

Wedbush Securities’s Portfolio CALA Stock Details CALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-1,025
Closed -$71K – 1028
2020
Q3 		$71K Buy
+1,025
New +$89.4K 0.01% 857
2019
Q4 		– Sell
-675
Closed -$42K – 1052
2019
Q3 		$42K Buy
+675
New +$54K ﹤0.01% 946
2017
Q1 		– Sell
-525
Closed -$34K – 895
2016
Q4 		$34K Sell
525
-200
-28% -$12.5K 0.01% 789
2016
Q3 		$47K Buy
725
+150
+26% +$9.67K 0.01% 794
2016
Q2 		$43K Buy
+575
New +$57.6K 0.01% 740

Other funds holding CALA

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DMPV
Delphi Management Partners VIII San Mateo, California $138M AUM 56.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Wedbush Securities's CALA Position: Q4 2020 in Review

Wedbush Securities sold out of Calithera Biosciences, Inc (CALA) in Q4 2020, closing a stake of 1,025 shares — an estimated $71K sold.

Wedbush Securities first reported a position in CALA in Q2 2016 and held it in 5 quarters. The position peaked at $71K in Q3 2020. 105 funds tracked by Wall St. Rank hold CALA as of Q4 2020.

  • Wedbush Securities reported no remaining Calithera Biosciences, Inc position as of Q4 2020 after selling out during the quarter.
  • Wedbush Securities sold 1,025 Calithera Biosciences, Inc shares in Q4 2020, an estimated $71K.
  • Wedbush Securities first reported a position in Calithera Biosciences, Inc in Q2 2016 and held it in 5 quarters.
  • Wedbush Securities's Calithera Biosciences, Inc position peaked at $71K in Q3 2020.
  • 105 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q4 2020.

Based on Wedbush Securities's 13F filing for Q4 2020, filed 16 Feb 2021.